A drug-sensitive genetic network masks fungi from the immune system.
Wheeler RT, Fink GR. · 2006
Read A drug-sensitive genetic network masks fungi from the immune system. by Wheeler RT, Fink GR. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1447670.txt.
Introduction
Fungi hide a loud alarm signal under a coat of proteins. Wheeler and Fink studied that masking trick in 2006. The signal is beta-glucan, a sugar chain in the fungal wall that stirs immune attack. A mild dose of an antifungal drug stripped the coat and exposed it.
Exposed fungi drew a much stronger response from immune cells. Using yeast mutants, Wheeler mapped a gene network that keeps the signal buried. Breaking parts of that network in a harmful fungus also exposed the sugar. Mouse immune cells then released more attack signals. The team suggests drugs that strip the mask could fight many fungi at once.
Catalog record
| CREATOR | Wheeler RT, Fink GR. |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A Drug-Sensitive Genetic Network Masks Fungi from the Immune System By Robert T Wheeler, Gerald R Fink, Brendan Cormack Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.0020035 ABSTRACT Abstract Fungal pathogens can be recognized by the immune system via their β-glucan, a potent proinflammatory molecule that is present at high levels but is predominantly buried beneath a mannoprotein coat and invisible to the host. To investigate the nature and significance of “masking” this molecule, we characterized the mechanism of masking and consequences of unmasking for immune recognition. We found that the underlying β-glucan in the cell wall of Candida albicans is unmasked by subinhibitory doses of the antifungal drug caspofungin, causing the exposed fungi to elicit a stronger immune response. Using a library of bakers' yeast (Saccharomyces cerevisiae) mutants, we uncovered a conserved genetic network that is required for concealing β-glucan from the immune system and limiting the host response. Perturbation of parts of this network in the pathogen C. albicans caused unmasking of its β-glucan, leading to increased β-glucan receptor-dependent elicitation of key proinflammatory cytokines from primary mouse macrophages. By creating an anti-inflammatory barrier to mask β-glucan, opportunistic fungi may promote commensal colonization and have an increased propensity for causing disease. Targeting the widely conserved gene network required for creating and maintaining this barrier may lead to novel broad-spectrum antimycotics. INTRODUCTION The innate immune system recognizes microbes based on their pathogen-associated molecular patterns (PAMPs), which provoke pathogen-specific responses tailored to meet the challenge [1]. This ensures that parasites, viruses, bacteria, and fungi are each attacked appropriately. Fungi are opportunistic pathogens responsible for occasionally severe disease in individuals with systemic disease [2,3]. Candida albicans, clinically the leading fungal pathogen, is recognized predominantly by two PAMPs (β-glucan and mannan), which account by weight for over 90% of its cell wall [4,5]. The cell wall of these and other fungi is tiered, with an outer layer of mannoproteins covalently linked to an inner core of β-glucan (Figure 1A). [Figure: Fungal β-Glucan Is Buried in the Cell Wall and Largely Inaccessible(A) Transmission electron micrograph demonstrating layer structure of fungal cell wall (courtesy of C. Rondeau). The plasma membrane is tightly connected to a thick layer of β-glucan network. Mannoproteins are linked to β-glucan and protrude outside of this layer to make up a dense coat. Schematic adapted from [5].(B–D) There is little β-glucan on live C. albicans or S. cerevisiae that is exposed and accessible to the anti-β-glucan antibody (B), the Dectin-CRD (C), or the Dectin-CRD-anti-Myc probe (D). The staining with anti-β-glucan and Dectin-CRD-anti-Myc is nearly indistinguishable, and is more specific than that with the directly labeled Dectin-CRD. The Dectin-CRD-anti-Myc has the same size as an antibody and the same specificity as Dectin-1. The difference in staining between the β-glucan-binding reagents (B and D versus C) is likely due to the size of the reagents (IgG has dimensions of approximately 95 Å × 171 Å [33], while the CRD of CD69, which is similar to the Dectin-1 CRD, has dimensions of 44 Å × 32 Å × 30 Å [34]) relative to the estimated pore size of the S. cerevisiae cell wall (58 Å [23]), and thus the monomeric Dectin-CRD likely has more access to smaller areas of exposed β-glucan.] The inner β-glucan layer is an essential cell wall component targeted by fungicidal antibodies, immune receptors, and the echinocandin class of antifungal drugs. Recent work has shown that anti-β-glucan antibodies can directly kill fungi and assist in the clearance of fungal infection [6]. The β-glucan receptor Dectin-1 also recognizes fungi and mediates the innate immune system's proinflammatory response [7]. The importance of this layer is also underscored by the effectiveness of the echinocandins, which bind and inhibit β-glucan synthase to cause cell lysis [8]. The importance of this inner β-glucan layer for immune targeting belies an interesting paradox. Although it accounts for a major fraction of the cell wall, β-glucan is buried underneath a thin but dense mannan coat (Figure 1A) [9]. This tiered arrangement of the cell surface raises several important issues: How do the cells of the immune system recognize β-glucan if it is coated with mannoproteins? Furthermore, what fungal genes function to “mask” the β-glucan from the immune system? In this study, we report the mechanisms and consequences of β-glucan masking and unmasking in the fungal-immune interaction. Growth of C. albicans in the presence of subinhibitory concentrations of the antifungal drug caspofungin exposes the normally masked β-glucan. We also define a conserved genetic network responsible for β-glucan masking in the genetically tractable, nonpathogenic model fungus Saccharomyces cerevisiae and confirm its requirement in the pathogen C. albicans. Exposure of β-glucan by drug treatment or mutation alters the way the fungi are recognized by immune cells, causing a β-glucan-dependent increase in the elicitation of tumor necrosis factor alpha (TNFα) from macrophages. For C. albicans, this unmasking transforms the fungi into cells that elicit a strong proinflammatory response. Thus, fungi camouflage the majority of their β-glucan from innate immune cells to lower the proinflammatory response to infection. RESULTS The Cell Wall β-Glucan Is Masked in S. cerevisiae and C. albicans Despite the high bulk levels of β-glucan throughout the fungal cell wall, C. albicans and laboratory strains of S. cerevisiae have little exposed β-glucan (Figure 1B–1D). The accessibility of β-glucan was measured in live fungal cells using three different reagents that colocalize: a monoclonal antibody directed against pure β-glucan [10], purified tagged Dectin-1 carbohydrate recognition domain (Dectin-CRD), and Dectin-CRD preincubated with fluorescently labeled antiepitope antibody (CRD-Myc; see Materials and Methods). Each of these three reagents interacts only weakly with intact cells of both C. albicans and laboratory strains of S. cerevisiae. Consistent with the biological relevance of masking of this proinflammatory molecule, intact cells of C. albicans and S. cerevisiae elicit little immune response when presented to macrophages. In agreement with previous reports [11], the primary areas of glucan-inhibitable binding of Dectin-1 and the anti-β-glucan antibody are the sites of previous cell wall remodeling (i.e., bud scars, birth scars, and bud necks). Wild-type fungal cells have abundant β-glucan in their cell walls but present little β-glucan to the immune system, and this trace amount is restricted to the sites of cell division. As most of the cells in a culture are newly generated, they have completed only one division and would be less efficiently recognized by immune molecules. Thus, it seems that fungi have developed conserved pathways to conceal the potent proinflammatory molecule β-glucan from the immune system. Fungal β-Glucan Is Exposed by Subinhibitory Doses of Caspofungin We reasoned that antifungal drugs that specifically target cell-wall biosynthetic pathways would disrupt the intricate architecture of the cell wall and heighten β-glucan exposure, “unmasking” the cells through uncoating or cell wall disorganization. To examine this possibility, we grew wild-type C. albicans overnight in the presence of subinhibitory doses of caspofungin (CF), a potent echinocandin that is a recent addition to the antifungal arsenal [8]. Remarkably, at CF concentrations that permit normal growth rates the drug caused exposure of β-glucan on the C. albicans cell surface (Figure 2A and 2B). At these drug concentrations, the cells had 10×–30× greater reactivity with the anti-β-glucan antibody. It is important to note that the fungi grow at these drug concentrations without